연구동향 분석
박사

비소세포폐암에서 microRNA-181a-5p에 의한 당과 지질 대사의 재조정 = microRNA 181a-5p Reprogramed Glucose and Lipid Metabolism in Non- Small Cell Lung Cancer

김정태 2020년

논문상세정보
인용/피인용
' 비소세포폐암에서 microRNA-181a-5p에 의한 당과 지질 대사의 재조정 = microRNA 181a-5p Reprogramed Glucose and Lipid Metabolism in Non- Small Cell Lung Cancer' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • aerobic glycolysis
  • cancer metabolism
  • lipid metabolism
  • lung-cancer
  • microrna
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
353 0

0.0%

' 비소세포폐암에서 microRNA-181a-5p에 의한 당과 지질 대사의 재조정 = microRNA 181a-5p Reprogramed Glucose and Lipid Metabolism in Non- Small Cell Lung Cancer' 의 참고문헌

  • p53 protects lung cancer cells against metabolic stress
    37 : 1575-1581 . [2010]
  • miR-30a suppresses lung cancer progression by targeting SIRT1
    [2017]
  • miR-181a-5p inhibits cell proliferation and migration by targeting Kras in non- small lung cancer A549 cells
    47 ( 8 ) :630-8 [2015]
  • miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase -14 .
    1 ; 75 ( 13 ) [2015]
  • The multifaceted roles of fatty acid synthesis in cancer
    16 : 732-749 . [2016]
  • The altered glucose metabolism in tumor and a tumor acidic microenvironment associated with extracellular matrix metalloproteinase inducer and monocarboxylate transporters
    7 : 23141-23155 . [2016]
  • The Warburg effect : evolving interpretations of an established concept
    [2015]
  • Targeting lactate dehydrogenase-A inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor initiating cells
    19 : 795-809 [2014]
  • Sirtuin Functions in Health and Disease
    21 : 1745-1755 [2007]
  • Simultaneous silencing of ACSL4 and induction of GADD45B in hepatocellularCarcinomaCells amplifies the synergistic therapeutic effect of aspirin and sorafenib
    [2017]
  • SIRT1 in B P-induced lung tumorigenesis .
    6 : 27113-27129 . [2015]
  • Role of multifaceted regulators inCancer glucose metabolism and theirClinical significance .
    7 : 1572-31585 . [2016]
  • Regulation ofCancerCell metabolism
    [2011]
  • Re-programming tumourCell metabolism to treatCancer : no lone target for lonidamine
    473 : 1503-1506 . [2016]
  • MicroRNA-146a inhibits epithelial mesenchymal transition in non-small cell lung cancer by targeting insulin receptor substrate 2.
    47 : 1545-1553 [2015]
  • MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis .
    1.231944444 [2016]
  • MicroRNA Signature Predicts Survival and Relapse in Lung Cancer
    13 : 48-57 [2008]
  • MicroRNA Expression Profiles in Korean Non-Small Cell Lung Cancer
    67 : 413-421 [2009]
  • Metabolic reprogramming and epithelial-to-mesenchymal transition in cancer
    284 : 3132-3144 [2017]
  • Metabolic Regulation by p53 Family Members .
    18 : 617-633 . [2013]
  • Metabolic Heterogeneity in Human Lung Tumors .
    164 : 681- 694 [2016]
  • Long-Chain Acyl- CoA Synthetases .
    [2008]
  • LncRNA CCAT1 negatively regulates miRNA-181a-5p to promote endometrial carcinoma cell proliferation and migration
    17 ( 5 ) :4259-4266
  • Lipid metabolism in cancer
    279 : 2610-2623 [2012]
  • Lactate Dehydrogenase B Is Required for the Growth of KRAS- Dependent Lung Adenocarcinomas
    19 : 773-84 [2013]
  • Knockdown of lactate dehydrogenase A suppresses tumor growth and metastasis of human hepatocellular carcinoma
    279 ( 20 ) :3898-910 [2012]
  • Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy .
    25 : 843-854 . [2008]
  • How does cancer cell metabolism affect tumor migration and invasion ?
    [2013]
  • Expression of miRNA-33 from an SREBP2 intron inhibits cholesterol export and fatty acid oxidation
    285 ( 44 ) :33652-61 [2010]
  • Expression of Sirtuin 1 and 2 Is Associated with Poor Prognosis in Non-Small Cell Lung Cancer Patients .
    10 : e0124670 . [2015]
  • Discovery , In Vivo Activity , and Mechanism of Action of a SmallMolecule p53 Activator
    13 : 454-463 . [2008]
  • Correlation of EGFR or KRAS mutation status with ( 18 ) F- FDG uptake on PET-CT scan in lung adenocarcinoma
    12 : e0175622 . [2017]
  • Cellular Fatty Acid Metabolism and Cancer
    18 : 153-161 . [2013]
  • Cancer metabolic reprogramming : importance , main features , and potentials for precise targeted anti-cancer therapies
    [2014]
  • Cancer genes and the pathways they control
    [2004]
  • Cancer cell metabolism : implications for therapeutic targets
    45 , e45 [2013]
  • Bisindole-PBD regulates breast cancer cell proliferation via SIRT-p53 axis
    16 : 1486-1501 . [2015]
  • Alternative fuels for cancer cells
    55 [2015]
  • Acyl-CoA Synthetase Isoforms 1 , 4 , and 5 Are Present in Different Subcellular Membranes in Rat Liver and Can Be Inhibited Independently
    [2001]
  • Aberrant cancer metabolism in epithelial mesenchymal transition and cancer metastasis : Mechanisms in cancer progression
    [2017]
  • ACSL4 promotes prostate cancer growth , invasion and hormonal resistance
    6 : 44849-44863 . [2015]
  • A microRNA expression signature of human solid tumors defines cancer gene targets
    [2006]